Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cardiokinetix logo — company profile

Cardiokinetix

Founded 2003 8 employees Series F Total: $112.50M Biotechnology, Health Care +1

General Information

Company Name Cardiokinetix
Founded Year 2003
Employees 8
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series F
Social

BounceWatch is an independent company data service, not affiliated with Cardiokinetix. To contact Cardiokinetix, visit cardiokinetix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cardiokinetix compare?

A PDF of Cardiokinetix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cardiokinetix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cardiokinetix

Cardiokinetix, founded in 2003, is a biotechnology and medical devices company based in Menlo Park, CA, dedicated to "Changing the Shape of Heart Failure®." The company's innovative product, the Parachute® Ventricular Partitioning Device, aims to address the unmet needs of heart failure patients worldwide, especially those who have suffered from heart attacks. With an estimated 23 million patients affected and the high economic burden of heart failure, Cardiokinetix's focus on improving overall cardiac function is crucial. The company received a Series F investment on 29 November 2016 from SV Health Investors. Despite the availability of drugs, devices, and surgical techniques, the mortality and readmission rates for heart failure patients remain high, presenting a significant market opportunity for Cardiokinetix.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series F Undisclosed 1
SV Health Investors
SV Health Investors
29 Nov 2016
Series F $50.00M 5
Edwards Lifesciences New Leaf Venture Partners SV Health Investors
Edwards Lifesciences, New Leaf Venture Partners +3
08 Dec 2014
Series E $23.00M 5
New Leaf Venture Partners SV Health Investors Panorama Capital
New Leaf Venture Partners, SV Health Investors +3
01 Mar 2013
Series E $4.00M 1
Panorama Capital
Panorama Capital
28 Feb 2013
Series E $21.00M 4
New Leaf Venture Partners SV Health Investors US Venture Partners
New Leaf Venture Partners, SV Health Investors +2
21 Sep 2011
Series C $14.50M 4
US Venture Partners Cutlass Capital Hambrecht & Quist Capital Management
US Venture Partners, Cutlass Capital +2
15 Jul 2008

Cardiokinetix Alternatives & Competitors

Cardiokinetix vs
PercAssist, Inc
PercAssist, Inc United States

Reinventing the Standard of Care in Mechanical Circulatory Support

Seed
9 employees
Health Care, Medical Devices

FAQ About Cardiokinetix

Cardiokinetix – Changing the Shape of Heart Failure® The Company, based in Menlo Park, CA, has developed a novel transcatheter implant called the Parachute® Ventricular Partitioning Device (Parachute). The Parachute intends to treat heart failure resulting from a heart attack in patients worldwid...
Cardiokinetix was founded in 2003.
Cardiokinetix operates in Biotechnology, Health Care and Medical Devices.
Cardiokinetix has approximately 8 employees.
Cardiokinetix has completed 6 funding rounds, raising a total of $112.50M. The latest funding stage is Series F.
Top alternatives and competitors to Cardiokinetix include PercAssist, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiokinetix and PercAssist, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cardiokinetix, https://bouncewatch.com/company/cardiokinetix, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout